Media headlines about Imprivata (NYSE:IMPR) have trended somewhat positive on Thursday, according to Accern Sentiment. Accern rates the sentiment of news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Imprivata earned a news impact score of 0.12 on Accern’s scale. Accern also assigned media headlines about the technology company an impact score of 46.0176886898083 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Imprivata (NYSE:IMPR) opened at $19.26 on Thursday. Imprivata has a twelve month low of $9.00 and a twelve month high of $20.32.
WARNING: “Somewhat Favorable News Coverage Somewhat Unlikely to Impact Imprivata (IMPR) Stock Price” was first posted by Community Financial News and is owned by of Community Financial News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this report can be read at https://www.com-unik.info/2017/12/07/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-imprivata-impr-stock-price.html.
Imprivata, Inc (Imprivata) is a United States-based healthcare information technology security company. The Company enables healthcare organizations to access, communicate and transact patient information securely. The Company offers Imprivata OneSign, Imprivata Cortext, Imprivata Confirm ID and Imprivata PatientSecure.
What are top analysts saying about Imprivata Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Imprivata Inc and related companies.